|
|
2001 |
2005 |
2007 |
|||||
|
Bio-generic |
Market Size |
Market Size |
Growth |
Market Size |
Growth |
|||
|
INR |
USD |
INR |
USD |
(Percent) |
INR |
USD |
(Percent) |
|
|
|
(crores) |
(millions) |
(crores) |
(millions) |
(crores) |
(millions) |
|
|
|
Erythropoietin (EPO) |
35.2 |
7.26 |
283.2 |
58.39 |
68 |
412 |
84.95 |
21 |
|
Interferon |
15.6 |
3.22 |
50 |
10.31 |
34 |
60.5 |
12.47 |
10 |
|
G-CSF (Filgrastim) |
11.6 |
2.39 |
200 |
41.24 |
104 |
294.8 |
60.78 |
21 |
|
Hepatitis BVaccine |
203.6 |
41.98 |
685.5 |
141.34 |
35 |
987.2 |
203.55 |
20 |
|
Streptokinase |
19.1 |
3.94 |
34.6 |
7.13 |
16 |
39.7 |
8.19 |
7 |
|
Combination Vaccine |
16.1 |
3.32 |
25.7 |
5.3 |
12 |
28.4 |
5.86 |
5 |
|
Rota Virus |
1.3 |
0.27 |
6.1 |
1.26 |
49 |
9.5 |
1.96 |
25 |
|
Typhoid Vaccine |
6.2 |
1.28 |
20.6 |
4.25 |
35 |
32.2 |
6.64 |
25 |
|
Total |
308.5 |
63.65 |
1,305.70 |
269.22 |
43 |
1,864.30 |
384.39 |
19 |
